US Stock MarketDetailed Quotes

NVIVQ INVIVO THERAPEUTICS HOLDING CORP

Watchlist
  • 0.370
  • 0.0000.00%
15min DelayClose Jul 15 16:00 ET
1.15MMarket Cap-0.11P/E (TTM)

INVIVO THERAPEUTICS HOLDING CORP Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
1.00%2.83M
-23.63%2.09M
-6.64%2.49M
7.58%10.65M
-15.72%2.46M
14.15%2.8M
18.18%2.73M
19.83%2.67M
8.83%9.9M
32.95%2.91M
Selling and administrative expenses
30.21%2.13M
-0.80%1.37M
-10.29%1.11M
-1.72%5.42M
-25.97%1.18M
22.25%1.63M
-0.07%1.38M
1.82%1.23M
7.00%5.52M
23.93%1.59M
-General and administrative expense
30.21%2.13M
-0.80%1.37M
-10.29%1.11M
-1.72%5.42M
-25.97%1.18M
22.25%1.63M
-0.07%1.38M
1.82%1.23M
7.00%5.52M
23.93%1.59M
Research and development costs
-39.81%703K
-47.00%715K
-3.49%1.38M
19.29%5.23M
-3.40%1.28M
4.47%1.17M
45.37%1.35M
41.40%1.43M
11.22%4.38M
45.70%1.32M
Operating profit
-1.00%-2.83M
23.63%-2.09M
6.64%-2.49M
-7.58%-10.65M
15.72%-2.46M
-14.15%-2.8M
-18.18%-2.73M
-19.83%-2.67M
-8.83%-9.9M
-32.95%-2.91M
Net non-operating interest income expense
188.89%130K
1,245.45%148K
15,500.00%156K
4,933.33%151K
94K
4,400.00%45K
1,000.00%11K
0.00%1K
-84.21%3K
0
Non-operating interest income
188.89%130K
1,245.45%148K
15,500.00%156K
----
----
4,400.00%45K
1,000.00%11K
0.00%1K
----
----
Total other finance cost
----
----
----
-4,933.33%-151K
----
----
----
----
---3K
----
Other net income (expense)
1K
350.00%9K
0
9K
-50.00%2K
1K
Other non- operating income (expenses)
--1K
----
----
350.00%9K
--0
----
----
--9K
-50.00%2K
--1K
Income before tax
2.11%-2.7M
28.76%-1.94M
12.17%-2.33M
-6.01%-10.49M
18.92%-2.36M
-12.40%-2.76M
-17.76%-2.72M
-19.43%-2.66M
-9.05%-9.9M
-32.85%-2.91M
Income tax
Net income
2.11%-2.7M
28.76%-1.94M
12.17%-2.33M
-6.01%-10.49M
18.92%-2.36M
-12.40%-2.76M
-17.76%-2.72M
-19.43%-2.66M
-9.05%-9.9M
-32.85%-2.91M
Net income continuous Operations
2.11%-2.7M
28.76%-1.94M
12.17%-2.33M
-6.01%-10.49M
18.92%-2.36M
-12.40%-2.76M
-17.76%-2.72M
-19.43%-2.66M
-9.05%-9.9M
-32.85%-2.91M
Minority interest income
Net income attributable to the parent company
2.11%-2.7M
28.76%-1.94M
12.17%-2.33M
-6.01%-10.49M
18.92%-2.36M
-12.40%-2.76M
-17.76%-2.72M
-19.43%-2.66M
-9.05%-9.9M
-32.85%-2.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
2.11%-2.7M
28.76%-1.94M
12.17%-2.33M
-6.01%-10.49M
18.92%-2.36M
-12.40%-2.76M
-17.76%-2.72M
-19.43%-2.66M
-9.05%-9.9M
-32.85%-2.91M
Basic earnings per share
56.06%-0.87
68.53%-0.62
56.19%-0.85
8.69%-6.83
52.74%-0.95
-10.61%-1.98
-17.26%-1.97
-2.65%-1.94
77.16%-7.48
13.32%-2.01
Diluted earnings per share
56.06%-0.87
68.53%-0.62
56.19%-0.85
8.69%-6.83
52.74%-0.95
-10.61%-1.98
-17.26%-1.97
-2.65%-1.94
77.16%-7.48
13.32%-2.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 1.00%2.83M-23.63%2.09M-6.64%2.49M7.58%10.65M-15.72%2.46M14.15%2.8M18.18%2.73M19.83%2.67M8.83%9.9M32.95%2.91M
Selling and administrative expenses 30.21%2.13M-0.80%1.37M-10.29%1.11M-1.72%5.42M-25.97%1.18M22.25%1.63M-0.07%1.38M1.82%1.23M7.00%5.52M23.93%1.59M
-General and administrative expense 30.21%2.13M-0.80%1.37M-10.29%1.11M-1.72%5.42M-25.97%1.18M22.25%1.63M-0.07%1.38M1.82%1.23M7.00%5.52M23.93%1.59M
Research and development costs -39.81%703K-47.00%715K-3.49%1.38M19.29%5.23M-3.40%1.28M4.47%1.17M45.37%1.35M41.40%1.43M11.22%4.38M45.70%1.32M
Operating profit -1.00%-2.83M23.63%-2.09M6.64%-2.49M-7.58%-10.65M15.72%-2.46M-14.15%-2.8M-18.18%-2.73M-19.83%-2.67M-8.83%-9.9M-32.95%-2.91M
Net non-operating interest income expense 188.89%130K1,245.45%148K15,500.00%156K4,933.33%151K94K4,400.00%45K1,000.00%11K0.00%1K-84.21%3K0
Non-operating interest income 188.89%130K1,245.45%148K15,500.00%156K--------4,400.00%45K1,000.00%11K0.00%1K--------
Total other finance cost -------------4,933.33%-151K-------------------3K----
Other net income (expense) 1K350.00%9K09K-50.00%2K1K
Other non- operating income (expenses) --1K--------350.00%9K--0----------9K-50.00%2K--1K
Income before tax 2.11%-2.7M28.76%-1.94M12.17%-2.33M-6.01%-10.49M18.92%-2.36M-12.40%-2.76M-17.76%-2.72M-19.43%-2.66M-9.05%-9.9M-32.85%-2.91M
Income tax
Net income 2.11%-2.7M28.76%-1.94M12.17%-2.33M-6.01%-10.49M18.92%-2.36M-12.40%-2.76M-17.76%-2.72M-19.43%-2.66M-9.05%-9.9M-32.85%-2.91M
Net income continuous Operations 2.11%-2.7M28.76%-1.94M12.17%-2.33M-6.01%-10.49M18.92%-2.36M-12.40%-2.76M-17.76%-2.72M-19.43%-2.66M-9.05%-9.9M-32.85%-2.91M
Minority interest income
Net income attributable to the parent company 2.11%-2.7M28.76%-1.94M12.17%-2.33M-6.01%-10.49M18.92%-2.36M-12.40%-2.76M-17.76%-2.72M-19.43%-2.66M-9.05%-9.9M-32.85%-2.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 2.11%-2.7M28.76%-1.94M12.17%-2.33M-6.01%-10.49M18.92%-2.36M-12.40%-2.76M-17.76%-2.72M-19.43%-2.66M-9.05%-9.9M-32.85%-2.91M
Basic earnings per share 56.06%-0.8768.53%-0.6256.19%-0.858.69%-6.8352.74%-0.95-10.61%-1.98-17.26%-1.97-2.65%-1.9477.16%-7.4813.32%-2.01
Diluted earnings per share 56.06%-0.8768.53%-0.6256.19%-0.858.69%-6.8352.74%-0.95-10.61%-1.98-17.26%-1.97-2.65%-1.9477.16%-7.4813.32%-2.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data